Cargando…
Antenatal Screening for Down Syndrome Using Serum Placental Growth Factor with the Combined, Quadruple, Serum Integrated and Integrated Tests
OBJECTIVE: To estimate the value of first or second trimester placental growth factor (PlGF) as an additional antenatal screening marker for Down syndrome. DESIGN: Nested case-control study. SETTING: Antenatal screening service. POPULATION OR SAMPLE: 532 Down syndrome pregnancies and 1,155 matched u...
Autores principales: | Wald, Nicholas J., Bestwick, Jonathan P., George, Lynne M., Huttly, Wayne J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463523/ https://www.ncbi.nlm.nih.gov/pubmed/23056541 http://dx.doi.org/10.1371/journal.pone.0046955 |
Ejemplares similares
-
Improvements in antenatal screening for Down's syndrome
por: Wald, N J, et al.
Publicado: (2013) -
Distribution of nuchal translucency in antenatal screening for Down's syndrome
por: Bestwick, J P, et al.
Publicado: (2010) -
Evaluation of a proposed mixture model to specify the distributions of nuchal translucency measurements in antenatal screening for Down's syndrome
por: Bestwick, J P, et al.
Publicado: (2010) -
Antenatal screening for Down’s syndrome: Revised nuchal translucency upper truncation limit due to improved precision of measurement
por: Vale, Stephen H, et al.
Publicado: (2020) -
Prevention of Neural Tube Defects: A Cross-Sectional Study of the Uptake of Folic Acid Supplementation in Nearly Half a Million Women
por: Bestwick, Jonathan P., et al.
Publicado: (2014)